Bisphosphonates

What you need to knowFor patients with osteoporosis, assess patient eligibility for treatment with bisphosphonate therapy by using a fracture risk assessment toolOral therapy should be taken on an empty stomach with high adherenceCheck renal function prior to prescribing intravenous therapyTreat for at least five years (oral) or three years (annual intravenous) before consideration of hiatusA shared decision making approach is highly valued by patients who are considering treatmentA 70 year old white woman presented to her general practitioner for her annual check-up. She weighs 62 kg and is 164 cm tall. She is a tobacco user (20 pack-year) with prior wrist fracture three years ago after a fall on ice. Dietary history revealed low calcium intake, and she does not take vitamin D supplements. Her mother had a hip fracture at age 74 years. Given these risk factors, you order a bone density scan (DEXA), which shows a femoral…
Read Original Article: Bisphosphonates »